K. Dickstein et al., PLASMA PROATRIAL NATRIURETIC FACTOR IS PREDICTIVE OF CLINICAL STATUS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, The American journal of cardiology, 76(10), 1995, pp. 679-683
Atrial stretch results in myocyte release of the prohormone atrial nat
riuretic factor (1-126). The N-terminal (1-98) fragment, proatrial nat
riuretic factor (proANF) is released on an equimolar basis with the C-
terminal (99-126) active hormone and may be assayed simply due to in v
itro stability. This study was undertaken to evaluate the relation bet
ween proANF and routinely available measures of clinical status. ProAN
F was sampled from 202 patients (median age 68 years [range 15 to 85],
77% men) recruited from an active outpatient heart failure clinic. Pa
tients were subgrouped according to New York Heart Association functio
nal class, radionuclide ejection fraction (EF), echocardiographic left
ventricular (LV) end-diastolic diameter, and Doppler-determined systo
lic pulmonary arterial pressure. The median proANF (pmol/L) values for
patients in New York Heart Association classes I, II, III, and IV wer
e 725, 1,527, 1,750, and 5,172, respectively. The proANF value for the
group with EF >40% was 1,534 versus 1,993 for EF less than or equal t
o 40% (p <0.05). The value for the group with LV diameter <60 mm was 8
38 versus 1,751 for LV diameter greater than or equal to 60 mm (p <0.0
1). the value for the group with systolic pulmonary artery pressure <4
5 mm Hg was 1,241 versus 2,660 for systolic pulmonary artery pressure
greater than or equal to 45 mm Hg (p <0.01). ProANF correlated better
than the other variables with New York Heart Association functional cl
ass and was more closely associated with noninvasive measurements than
New York Heart Association functional class. Odds ratio estimates dem
onstrated a substantially increased risk of LV dysfunction and dilatat
ion, pulmonary hypertension, and New York Heart Association functional
class III or IV with increasing proANF valves. These data clearly ind
icate that the concentration of proANF is related to the degree of cli
nical heart failure. Analysis is simple and should be of practical val
ue as a supplement in the routine assessment of cardiac status in this
heterogeneous population.